These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19660103)

  • 1. The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC).
    Ioannidis G; Papaioannou A; Thabane L; Gafni A; Hodsman A; Kvern B; Walsh A; Jiwa F; Adachi JD
    BMC Med Educ; 2009 Aug; 9():54. PubMed ID: 19660103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing care in osteoporosis: the Canadian quality circle project.
    Ioannidis G; Thabane L; Gafni A; Hodsman A; Kvern B; Johnstone D; Plumley N; Salach L; Jiwa F; Adachi JD; Papaioannou A
    BMC Musculoskelet Disord; 2008 Oct; 9():130. PubMed ID: 18828906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
    Kennedy CC; Ioannidis G; Thabane L; Adachi JD; Marr S; Giangregorio LM; Morin SN; Crilly RG; Josse RG; Lohfeld L; Pickard LE; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
    Trials; 2015 May; 16():214. PubMed ID: 25962885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Quality Circle pilot project in osteoporosis: rationale, methods, and feasibility.
    Ioannidis G; Papaioannou A; Thabane L; Gafni A; Hodsman A; Kvern B; Johnstone D; Plumley N; Baldwin A; Doupe M; Katz A; Salach L; Adachi JD
    Can Fam Physician; 2007 Oct; 53(10):1694-700. PubMed ID: 17934033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family physicians' personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing.
    Ioannidis G; Papaioannou A; Thabane L; Gafni A; Hodsman A; Kvern B; Walsh A; Jiwa F; Adachi JD
    Popul Health Manag; 2009 Jun; 12(3):131-8. PubMed ID: 19534577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial.
    Majumdar SR; Johnson JA; McAlister FA; Bellerose D; Russell AS; Hanley DA; Morrish DW; Maksymowych WP; Rowe BH
    CMAJ; 2008 Feb; 178(5):569-75. PubMed ID: 18299546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.
    Jennings LA; Auerbach AD; Maselli J; Pekow PS; Lindenauer PK; Lee SJ
    J Am Geriatr Soc; 2010 Apr; 58(4):650-7. PubMed ID: 20398147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.
    Majumdar SR; Johnson JA; Bellerose D; McAlister FA; Russell AS; Hanley DA; Garg S; Lier DA; Maksymowych WP; Morrish DW; Rowe BH
    Osteoporos Int; 2011 Jan; 22(1):223-30. PubMed ID: 20358359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial.
    Cranney A; Lam M; Ruhland L; Brison R; Godwin M; Harrison MM; Harrison MB; Anastassiades T; Grimshaw JM; Graham ID
    Osteoporos Int; 2008 Dec; 19(12):1733-40. PubMed ID: 18629567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Roux S; Gaboury I; Gionet-Landry N; Garant MP; Beaulieu MC; Carrier N; Cabana F; Boire G
    Osteoporos Int; 2018 Apr; 29(4):961-971. PubMed ID: 29445831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
    Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
    Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.
    Gu T; Eisenberg Lawrence DF; Stephenson JJ; Yu J
    Clin Interv Aging; 2016; 11():1-8. PubMed ID: 26929609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of osteoporosis in the Middle East and North Africa: a survey of physicians' perceptions and practices.
    Beshyah SA; Al-Saleh Y; El-Hajj Fuleihan G
    Arch Osteoporos; 2019 Jun; 14(1):60. PubMed ID: 31175470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007.
    Born R; Zwahlen M
    BMC Musculoskelet Disord; 2013 Jan; 14():10. PubMed ID: 23289751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sample of Canadian orthopedic surgeons expressed willingness to participate in osteoporosis management for fragility fracture patients.
    Bogoch ER; Snowden E
    Can J Surg; 2008 Feb; 51(1):8-13; quiz 14. PubMed ID: 18248700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving osteoporosis care in high-risk home health patients through a high-intensity intervention.
    Outman RC; Curtis JR; Locher JL; Allison JJ; Saag KG; Kilgore ML
    Contemp Clin Trials; 2012 Jan; 33(1):206-12. PubMed ID: 22005175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific.
    Korthoewer D; Chandran M;
    Arch Osteoporos; 2012; 7():193-200. PubMed ID: 23225297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research.
    Curtis JR; Arora T; Xi J; Silver A; Allison JJ; Chen L; Saag KG; Schenck A; Westfall AO; Colón-Emeric C
    Osteoporos Int; 2009 Nov; 20(11):1921-7. PubMed ID: 19319619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives.
    Weaver JP; Olsson K; Sadasivan R; Modi A; Sen S
    J Womens Health (Larchmt); 2017 Dec; 26(12):1302-1311. PubMed ID: 28994642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.